Protecting life science patents in Latin America
Regimes for protecting pharmaceutical and biotechnological products via patents are slowly but steadily improving in many Latin American countries. Managing IP invited Alejandro Luna of Olivares & Cia, Guillermo Carey of HarneckerCarey Carey y CÃa and in-house counsel Regina Kuchle to discuss some promising developments and continuing challenges
EM: What regulatory changes have most impacted biotechnology and pharmaceutical patents recently?
AL: There was an amendment to the Mexican General Health Law in June 2009 which defined biotechnological drugs and allowed for the approval of follow-on biologics, or biocomparables. ...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.